A physician on Build.MD writes a script for a weight loss program during a regular office visit. The patient's next question is the obvious one: where does this actually go?
A brand building a program on Build.MD asks a version of the same question earlier, before a single patient exists: who fills these prescriptions, and how does a program cover patients in fifty states without fifty separate pharmacy relationships?
Both questions have the same answer. Here's how fulfillment actually works.
What happens after a provider prescribes
Once a provider decides treatment is appropriate and writes the prescription, it doesn't sit in a queue for someone to place by hand. It's routed to a licensed pharmacy selected for what's being prescribed, and the patient is kept updated as it moves through fulfillment. Nothing is stocked or dispensed at a practice's office or a brand's headquarters — there's no inventory to manage on either side.
Two kinds of medication, two kinds of pharmacy
Fulfillment splits along a line that matters more than it might look from outside: whether the medication is FDA-approved or compounded.
FDA-approved medications — sildenafil and tadalafil in the men's health program, Wegovy and Zepbound in the brand GLP-1 program — are dispensed through standard licensed pharmacies, the same category of pharmacy that fills a prescription from any doctor's office.
Compounded medications work differently. Therapies in the weight loss and peptide therapy programs are prepared by a licensed 503A pharmacy for that individual patient, after a provider has evaluated them and decided the therapy is appropriate. Compounded medications — including compounded semaglutide and tirzepatide — are not FDA-approved, no matter how familiar the underlying drug is.
A provider's prescription decides which path a given patient is on. Neither path requires the practice or the brand to source, store, or ship anything.
Why this is a harder problem than it looks
Building this from scratch is one of the slower, harder parts of standing up a prescription program. Pharmacy licensing varies state to state, and a compounding pharmacy and a standard retail pharmacy aren't interchangeable for a given prescription. A program that wants to operate nationally needs both kinds of pharmacy relationship, in enough states to matter, before it can see its first patient.
On Build.MD, that relationship layer already exists: vetted 503A and 503B pharmacy partners for compounded medications, and licensed pharmacies for FDA-approved ones, covering all 50 states and DC. That's part of why a program can go live in as fast as 14 days — the pharmacy side isn't something a new practice or brand has to build first.
What this means if you're a practice
You prescribe during the visit, or virtually afterward, the same as ever. You don't need to stock anything, negotiate with a compounding pharmacy, or work out which pharmacy can legally fill a given prescription in your state. Routing works the same way whether the prescription came from you in the exam room or from a provider covering a virtual visit. What changes is what you no longer have to build yourself: a pharmacy relationship, a fulfillment process, a way to track where a script is.
What this means if you're a brand
You're not becoming a pharmacy, and you don't need to. Build.MD isn't a pharmacy either — it's the layer that routes an already-written prescription to one. If your program includes compounded therapies, routing goes to a 503A partner; for FDA-approved medications, it goes to a licensed pharmacy that carries the drug. Either way, the relationships and the routing already exist, so your team's time stays on the brand, the intake experience, and the patient relationship, not on pharmacy logistics.
What Build.MD doesn't do
Worth being direct about the boundary. Build.MD doesn't manufacture or compound anything, and it isn't itself a pharmacy. It doesn't decide what a given patient should be prescribed — a provider does that, after an individual evaluation. What the platform does is route an already-written prescription to the right kind of licensed pharmacy and keep the patient posted while it's filled.
Where to start
If you're a practice deciding whether to add a program, the pharmacy side isn't something you need to plan for. What a cash-pay program actually adds covers the rest of what changes and what doesn't, and the practice page has the specifics for your patients. If you're a brand weighing whether to build this yourself or route through an existing back end, the brand page covers what's already built versus what you'd own. Either way, tell us about your practice or your brand and we'll confirm fit before either of us spends more time.
Some programs include compounded or off-label therapies. Treatment appropriateness is determined by a licensed provider after individual evaluation. Build.MD does not provide medical care directly; all clinical services are provided by Access Plus Medical or its affiliated providers. Compounded medications are not FDA-approved and are prepared by licensed pharmacies for individual patients.
← All posts